Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality worldwide. The impact of ASCVD is largely known on the national, state, and local level. Arizona is listed as one of the state with the highest prevalence of this disease. Directions for the treatment and avoidance of ASCVD includes annual lipid panels and statin therapy as first-line treatments if lifestyle modifications prove futile. Increasing the number of patients being screened for ASCVD risk is paramount to decreasing morbidity and mortality associated with this condition. The location of the project site, Mesa, Arizona, has a large population of patients requiring annual lipid monitoring; however, and low number of patients have their ASCVD risk scores calculated at their visits. The main objectives aimed to evaluate the utility and effectiveness of an evidence-based ASCVD risk calculator tool for patients and providers at a privately-owned family practice clinic in Mesa, Arizona.
